|
Enrocat flavour
|
25 mg/ml
|
V/DCP/20/0016
|
LIVISTO Int'l, S.L., Spānija
|
QJ01MA90
|
cats
|
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Enrofloxacin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Labiana Life Sciences S.A., Spānija;aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] 27022020LI (27-Feb-2020)
|
| Labelling text: |
[PDF] 27022020M (27-Feb-2020)
|
| Summary of product characteristics: |
[PDF] 27022020ZA (27-Feb-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/20/0016-01 |
25 mg/ml |
1 |
ABPE pudele, 8,5 ml |
-
|
|